Dupont Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Dupont Capital Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-18,136	Closed	-$1.51M	–	571
2023 Q2	$1.51M	Sell	18,136 -1,422	-7%	-$119K	0.07%	124
2023 Q1	$1.49M	Hold	19,558	–	–	0.07%	141
2022 Q4	$1.62M	Sell	19,558 -1,766	-8%	-$143K	0.08%	195
2022 Q3	$1.69M	Sell	21,324 -1,371	-6%	-$116K	0.1%	207
2022 Q2	$1.69M	Hold	22,695	–	–	0.08%	259
2022 Q1	$2.04M	Hold	22,695	–	–	0.08%	230
2021 Q4	$2.54M	Hold	22,695	–	–	0.09%	208
2021 Q3	$2.85M	Buy	+22,695	New	+$2.92M	0.09%	228

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Dupont Capital Management's XBI Position: Q3 2023 in Review

Dupont Capital Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2023, closing a stake of 18,136 shares — an estimated $1.51M sold.

Dupont Capital Management first reported a position in XBI in Q3 2021 and held it in 8 quarters. The position peaked at $2.85M in Q3 2021. 679 funds tracked by Wall St. Rank hold XBI as of Q3 2023.

Dupont Capital Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2023 after selling out during the quarter.
Dupont Capital Management sold 18,136 State Street SPDR S&P Biotech ETF shares in Q3 2023, an estimated $1.51M.
Dupont Capital Management first reported a position in State Street SPDR S&P Biotech ETF in Q3 2021 and held it in 8 quarters.
Dupont Capital Management's State Street SPDR S&P Biotech ETF position peaked at $2.85M in Q3 2021.
679 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2023.

Based on Dupont Capital Management's 13F filing for Q3 2023, filed 27 Oct 2023.